CORVUS PHARMACEUTICALS INC

Ticker: CRVS CUSIP: 221015100 Class: Common Stock

TOWERVIEW LLC's Holding History (CIK: 0001166573)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 140,000 Value ($000) $1,078 Avg Close $7.89 Range $6.39 - $9.60
Q3 2025
Shares 170,000 Value ($000) $1,253 Avg Close $5.12 Range $3.71 - $7.45
Q2 2025
Shares 170,000 Value ($000) $680 Avg Close $3.64 Range $2.54 - $4.62
Q1 2025
Shares 127,500 Value ($000) $405 Avg Close $4.71 Range $3.08 - $6.47
Q4 2024
Shares 77,500 Value ($000) $415 Avg Close $7.47 Range $3.77 - $10.00
Q3 2024
Shares 117,500 Value ($000) $620 Avg Close $3.59 Range $1.75 - $6.15
Q2 2024
Shares 400,000 Value ($000) $728 Avg Close $1.86 Range $1.30 - $2.35
Q1 2024
Shares 382,500 Value ($000) $681 Avg Close $2.09 Range $1.65 - $2.58
Q4 2023
Shares 436,873 Value ($000) $769 Avg Close $1.46 Range $1.05 - $1.92
Q3 2023
Shares 342,478 Value ($000) $500 Avg Close $2.11 Range $1.37 - $3.16
Q2 2023
Shares 205,000 Value ($000) $469 Avg Close $2.08 Range $0.72 - $4.19